Immunogenetics Laboratory, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.
Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
J Mol Diagn. 2018 Sep;20(5):703-715. doi: 10.1016/j.jmoldx.2018.05.009. Epub 2018 Jun 26.
The highly polymorphic human leukocyte antigen (HLA) genes, located in the human major histocompatibility complex, encode the class I and II antigen-presenting molecules, which are centrally involved in the immune response. HLA typing is used for several clinical applications, such as transplantation, pharmacogenetics, and diagnosis of autoimmune disease. HLA typing is highly complex because of the homology of HLA genes and pseudogenes and the extensive polymorphism in the population. The Centers for Disease Control and Prevention established the Genetic Testing Reference Materials Coordination Program (GeT-RM) in partnership with the genetics community to improve the availability of genomic DNA reference materials necessary for quality assurance of genetic laboratory testing. The GeT-RM together with three clinical laboratories and the Coriell Cell Repositories have characterized genomic DNA obtained from a panel of 108 cell lines for all HLA classic polymorphic loci: HLA-A, B, C, DRB1, DRB3, DRB4, DRB5, DQA1, DQB1, DPA1, and DPB1. The goal was to develop a publicly available and renewable source of well-characterized genomic DNA reference materials to support molecular HLA typing assay development, validation, and verification, quality control, and proficiency testing. These genomic DNA samples are publicly available from the National Institutes of General Medical Science Repository at the Coriell Cell Repositories.
高度多态性的人类白细胞抗原 (HLA) 基因位于人类主要组织相容性复合体中,编码 I 类和 II 类抗原呈递分子,这些分子在免疫反应中起着核心作用。HLA 分型用于多种临床应用,如移植、药物遗传学和自身免疫性疾病的诊断。由于 HLA 基因和假基因的同源性以及人群中广泛的多态性,HLA 分型非常复杂。疾病控制和预防中心与遗传学社区合作建立了遗传测试参考材料协调计划 (GeT-RM),以提高遗传实验室测试质量保证所需的基因组 DNA 参考材料的可用性。GeT-RM 与三个临床实验室和科里尔细胞库一起,对来自 108 个细胞系的基因组 DNA 进行了所有 HLA 经典多态性位点的特征描述:HLA-A、B、C、DRB1、DRB3、DRB4、DRB5、DQA1、DQB1、DPA1 和 DPB1。目标是开发一种可公开获得和可再生的、经过充分表征的基因组 DNA 参考材料来源,以支持分子 HLA 分型测定的开发、验证和验证、质量控制和能力验证。这些基因组 DNA 样本可从科里尔细胞库的国立普通医学科学研究所知识库中公开获得。